James L Tyree - Net Worth and Insider Trading
James L Tyree Net Worth
The estimated net worth of James L Tyree is at least $18 Million dollars as of 2024-11-08. James L Tyree is the Executive Vice President of Abbott Laboratories and owns about 132,176 shares of Abbott Laboratories (ABT) stock worth over $15 Million. James L Tyree is the Director of Innoviva Inc and owns about 50,697 shares of Innoviva Inc (INVA) stock worth over $1 Million. James L Tyree is also the Director of ChemoCentryx Inc and owns about 19,138 shares of ChemoCentryx Inc (CCXI) stock worth over $994,985. Besides these, James L Tyree also holds Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) . Details can be seen in James L Tyree's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James L Tyree has not made any transactions after 2024-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James L Tyree
James L Tyree Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James L Tyree owns 5 companies in total, including ChemoCentryx Inc (CCXI) , Assertio Holdings Inc (ASRT) , and Innoviva Inc (INVA) among others .
Click here to see the complete history of James L Tyree’s form 4 insider trades.
Insider Ownership Summary of James L Tyree
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CCXI | ChemoCentryx Inc | 2022-06-09 | director |
ASRT | Assertio Holdings Inc | 2024-03-14 | director |
INVA | Innoviva Inc | 2016-05-18 | director |
2009-02-27 | Senior Vice President | ||
2024-09-11 | director |
James L Tyree Latest Holdings Summary
James L Tyree currently owns a total of 5 stocks. Among these stocks, James L Tyree owns 132,176 shares of Abbott Laboratories (ABT) as of February 27, 2009, with a value of $15 Million and a weighting of 86.93%. James L Tyree owns 50,697 shares of Innoviva Inc (INVA) as of May 18, 2016, with a value of $1 Million and a weighting of 5.77%. James L Tyree also owns 19,138 shares of ChemoCentryx Inc (CCXI) as of June 9, 2022, with a value of $994,985 and a weighting of 5.61%. The other 2 stocks Assertio Holdings Inc (ASRT) , Genelux Corp (GNLX) have a combined weighting of 1.69% among all his current holdings.
Latest Holdings of James L Tyree
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ABT | Abbott Laboratories | 2009-02-27 | 132,176 | 116.59 | 15,410,400 |
INVA | Innoviva Inc | 2016-05-18 | 50,697 | 20.18 | 1,023,065 |
CCXI | ChemoCentryx Inc | 2022-06-09 | 19,138 | 51.99 | 994,985 |
ASRT | Assertio Holdings Inc | 2024-03-14 | 188,251 | 0.85 | 160,013 |
GNLX | Genelux Corp | 2024-09-11 | 47,521 | 2.93 | 139,237 |
Holding Weightings of James L Tyree
James L Tyree Form 4 Trading Tracker
According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Abbott Laboratories (ABT) over the past 5 years. The most-recent trade in Abbott Laboratories is the sale of 10,454 shares on February 27, 2009, which brought James L Tyree around $498,447.
According to the SEC Form 4 filings, James L Tyree has made a total of 0 transactions in Innoviva Inc (INVA) over the past 5 years. The most-recent trade in Innoviva Inc is the sale of 813 shares on May 18, 2016, which brought James L Tyree around $8,512.
According to the SEC Form 4 filings, James L Tyree has made a total of 4 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in ChemoCentryx Inc is the sale of 3,863 shares on June 9, 2022, which brought James L Tyree around $99,125.
More details on James L Tyree's insider transactions can be found in the Insider Trading History of James L Tyree table.Insider Trading History of James L Tyree
- 1
James L Tyree Trading Performance
James L Tyree Ownership Network
Ownership Network List of James L Tyree
Ownership Network Relation of James L Tyree
James L Tyree Owned Company Details
What does ChemoCentryx Inc do?
Who are the key executives at ChemoCentryx Inc?
James L Tyree is the director of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .
ChemoCentryx Inc (CCXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ChemoCentryx Inc Insider Transactions
James L Tyree Mailing Address
Above is the net worth, insider trading, and ownership report for James L Tyree. You might contact James L Tyree via mailing address: 100 Abbott Park Road, Abbott Park Il 60064-6400.